Vertex Pharmaceuticals (NQ:VRTX)
436.81
+2.30
(+0.53%)
Streaming Delayed Price
Updated: 1:55 PM EDT, May 26, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 326,759 |
| Open | 437.99 |
| Bid (Size) | 436.58 (40) |
| Ask (Size) | 437.05 (40) |
| Prev. Close | 434.52 |
| Today's Range | 433.79 - 441.99 |
| 52wk Range | 362.50 - 507.92 |
| Shares Outstanding | 259,428,394 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Vertex (VRTX) Q1 2026 Earnings Call Transcript ↗
May 04, 2026
Vertex Pharmaceuticals Reports Mixed Q1 Results ↗
May 04, 2026
Vertex Reports First Quarter 2026 Financial Results
May 04, 2026
Vertex (VRTX) Q2 2025 Earnings Call Transcript ↗
May 04, 2026
3 Growth Stocks That Could Generate 10X Returns ↗
April 29, 2026
3 of Wall Street’s Favorite Stocks Worth Your Attention
April 29, 2026
3 Market-Beating Stocks to Consider Right Now
April 28, 2026
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 436.81
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 05/26/26 01:55 PM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 113.32B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 113B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.